Bryan G. Allen, MD, PhD
- Associate Professor
- Department: Radiation Oncology
- Program: Program 2: Experimental Therapeutics (ET)
- Membership Status: Full Member
- Holden Leadership Role: Program Leader
Holden Comprehensive Cancer Center Research Executive Committee
Holden Comprehensive Cancer Center Research Executive Committee
Girish Bathla, MBBS, MMeD (DR), FRCR, DMRD
- Clinical Assistant Professor
- Clinical Neuroradiology Research Director
- Department: Radiology
- Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
- Membership Status: Affiliate Member
- Holden Leadership Role: Director
Gail A. Bishop, PhD
- Associate Director of Basic Research for Holden Comprehensive Cancer Center
- Professor
- Department: Microbiology, Internal Medicine
- Program: Program 1: Cancer Genes and Pathways (CGP)
- Membership Status: Full Member
- Holden Leadership Role: Associate Director, Basic Research
Elizabeth Chrischilles, PhD
- Associate Director for Population Science and Community Engagement
- Department of Epidemiology Chair
- Pomerantz Chair in Public Health
- Health Effectiveness Research Center Director
- Professor
- Department: Epidemiology
- Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
- Membership Status: Full Member
- Holden Leadership Role: Associate Director, Population Science
Tina R. Devery, MHA
- Associate Director of Administration for Holden Comprehensive Cancer Center
- Department:
- Program:
- Membership Status:
- Holden Leadership Role: Associate Director
Michael D. Henry, PhD
- Deputy Director for Research for Holden Comprehensive Cancer Center
- Professor
- Department: Molecular Physiology and Biophysics, Pathology, Urology
- Program: Program 1: Cancer Genes and Pathways (CGP)
- Membership Status: Full Member
- Holden Leadership Role: Deputy Director, Research
Richard M. Hoffman, MD, MPH
- Professor
- Department: Internal Medicine, Epidemiology
- Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
- Membership Status: Full Member
- Holden Leadership Role: Program Co-Leader
Hisakazu Hoshi, MD
- Co-Leader Melanoma MOG
- Associate Deputy Director for Clinical Cancer Services for Holden Comprehensive Cancer Center
- Clinical Professor
- Department: Surgery
- Program: Program 2: Experimental Therapeutics (ET)
- Membership Status: Affiliate Member
- Holden Leadership Role: Associate Deputy Director, Clinical Cancer Services
Jon C. Houtman, PhD
- Associate Director of Career Enhancement at Holden Comprehensive Cancer Center
- Associate Professor
- Department: Microbiology, Internal Medicine
- Program: Program 1: Cancer Genes and Pathways (CGP)
- Membership Status: Full Member
- Holden Leadership Role: Associate Director, Career Enhancement
Kimberly K. Leslie, MD
- Department of Obstetrics and Gynecology Chair
- Professor
- Department: Obstetrics and Gynecology
- Program: Program 2: Experimental Therapeutics (ET)
- Membership Status: Full Member
- Holden Leadership Role: Associate Director
Charles F. Lynch, MD, PhD
- Professor
- Department: Epidemiology and Pathology, Associate Head for Research, Epidemiology; Medical Director, State Health Registry of Iowa
- Program: Program 4: Cancer Epidemiology and Population Science (CEPS)
- Membership Status: Full Member
- Holden Leadership Role: Program Leader
Yusuf Menda, MD
- Professor
- Department: Radiology
- Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
- Membership Status: Full Member
- Holden Leadership Role: Program Co-Leader
Mohammed M. Milhem, MBBS
- Holden Chair of Experimental Therapeutics
- Associate Director of Clinical Research at Holden Comprehensive Cancer Center
- Director of the Melanoma Program
- Chief Section of Oncology, Department of Internal Medicine
- Clinical Professor
- Department: Internal Medicine
- Program: Program 2: Experimental Therapeutics (ET)
- Membership Status: Full Member
- Holden Leadership Role: Deputy Director
Dawn E. Quelle, PhD
- Professor
- Department: Pharmacology
- Program: Program 1: Cancer Genes and Pathways (CGP)
- Membership Status: Full Member
- Holden Leadership Role: Program Leader
Aliasger K. Salem, PhD
- Professor
- Department: Pharmaceutics
- Program: Program 2: Experimental Therapeutics (ET)
- Membership Status: Full Member
- Holden Leadership Role: Program Co-Leader
Douglas R. Spitz, Jr., PhD
- Professor
- Department: Radiation Oncology, Pathology
- Program: Program 3: Free Radical Metabolism and Imaging (FRMI)
- Membership Status: Full Member
- Holden Leadership Role: Program Leader
Michael H. Tomasson, MD
- Professor
- Department: Internal Medicine
- Program: Program 1: Cancer Genes and Pathways (CGP)
- Membership Status: Full Member
- Holden Leadership Role: Program Co-Leader